C92.1 Chronic myeloid leukemia, BCR/ABL-positive

Name of the Condition

• Chronic myeloid leukemia, BCR/ABL-positive

Summary

Chronic myeloid leukemia (CML) is a type of cancer that affects the bone marrow and blood, characterized by the overproduction of abnormal white blood cells. The BCR/ABL-positive subtype is defined by the presence of the BCR/ABL fusion gene, a key genetic abnormality that drives the disease. This condition typically progresses slowly and may be managed with targeted therapies.

Causes

CML is primarily caused by a genetic mutation resulting in the BCR/ABL fusion gene. This gene produces an abnormal tyrosine kinase protein that disrupts normal cell regulation, leading to uncontrolled proliferation of myeloid cells. The mutation occurs spontaneously in most cases and is not inherited.

Risk Factors

• Age: Most common in adults, with incidence increasing after age 60.
• Gender: Slightly more prevalent in males.
• Exposure to high levels of ionizing radiation.
• No significant family history or inherited genetic predisposition.

Symptoms

• Fatigue or weakness
• Unexplained weight loss or fever
• Night sweats
• Enlarged spleen or abdominal discomfort
• Frequent infections
• Anemia or easy bruising/bleeding

Diagnosis

Diagnosis involves blood tests to detect abnormal white blood cell counts, followed by a bone marrow biopsy to confirm the presence of the BCR/ABL fusion gene. Cytogenetic or molecular testing may also be used to identify the specific genetic abnormality.

Treatment Options

• Tyrosine kinase inhibitors (TKIs) like imatinib, dasatinib, or nilotinib, which target the BCR/ABL protein.
• Interferon therapy in some cases.
• Allogeneic stem cell transplantation for eligible patients.
• Regular monitoring to assess treatment response and adjust therapy.

Prognosis and Follow-Up

With targeted therapy, many patients achieve long-term remission. Prognosis depends on factors like age, response to treatment, and disease phase at diagnosis. Follow-up includes regular blood tests and molecular monitoring to detect recurrence early.

Complications

• Disease progression to accelerated or blast phase.
• Resistance to targeted therapy.
• Increased risk of infections due to low white blood cell counts.
• Anemia or thrombocytopenia from bone marrow dysfunction.

Lifestyle & Prevention

• Avoid exposure to ionizing radiation when possible.
• Maintain a balanced diet and regular exercise to support overall health.
• Follow medical advice for monitoring and treatment adherence.

When to Seek Professional Help

Seek care if experiencing persistent fatigue, unexplained weight loss, fever, night sweats, or abdominal swelling. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

Document the presence of the BCR/ABL fusion gene to confirm the diagnosis. Ensure coding aligns with clinical documentation, as this genetic marker is critical for accurate classification. Verify that the code reflects the chronic nature of the condition and any treatment response noted in the record.